تفاعل #938599
ord-6923c2c26085471e833369b21f946e53
معادلة التفاعل
المتفاعلات
الكواشف
ظروف التفاعل
المعالجة
- 1workup.STIRRINGAfter stirring for 25 minutes at -78° C.
- 2درجة الحرارةto warm to 0° C. over a period of 40 minutes
- 3workup.DISTILLATIONThe solvent was distilled off in vacuo at 0° C.
- 4workup.DISSOLUTIONthe residue was dissolved in ethyl acetate (30 ml)
- 5غسيلwashed with brine, aqueous sodium bicarbonate, brine, and saturated aqueous sodium chloride
- 6تجفيفAfter drying over magnesium sulfate
- 7استخلاصthe ethyl acetate extract
- 8ترشيحwas filtered
- 9أخرىevaporated in vacuo
- 10أخرىThe residual oil (381.2 mg) was chromatographed on silica gel (11 g)
- 11غسيلeluting with a mixture of ethyl acetate and hexane (1:10→1:5)
الإجراء التجريبي
To a solution of methyl 2-[(3R,4R)-3-isocyano-2-oxo-4-allylazetidin-1-yl]-3-methylbut-2-enoate (198.0 mg) in tetrahydrofuran (3.96 ml) was added dropwise a solution of n-butyl lithium (0.634 ml of 1.51 M solution in hexane) at -78° C. over a period of 5 minutes. After stirring for 15 minutes at -78° C., the reaction mixture was added with a solution of acetone (0.0713 ml) in tetrahydrofuran (0.642 ml) at -78° C. over a period of 5 minutes. After stirring for 25 minutes at -78° C., the reaction mixture was added dropwise with a solution of benzyl chloroformate (0.1274 ml) in tetrahydrofuran (1.15 ml) at -78° C. over a period of 5 minutes. The resulting solution was allowed to warm to 0° C. over a period of 40 minutes and added with acetic acid (0.0639 ml) at 0° C. The solvent was distilled off in vacuo at 0° C. and the residue was dissolved in ethyl acetate (30 ml) and washed with brine, aqueous sodium bicarbonate, brine, and saturated aqueous sodium chloride. After drying over magnesium sulfate, the ethyl acetate extract was filtered and evaporated in vacuo. The residual oil (381.2 mg) was chromatographed on silica gel (11 g) eluting with a mixture of ethyl acetate and hexane (1:10→1:5) to give methyl 2-[(3R,4R)-3-(1-benzyloxycarbonyloxy-1-methylethyl)-3-isocyano-2-oxo-4-allylazetidin-1-yl]-3-methylbut-2-enoate (221.2 mg) as an oil.